IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down

Ironwood Pharmaceuticals (IRWD) reported adjusted earnings of 2 cents per share for the fourth quarter of 2024, missing the Zacks Consensus Estimate of 10 cents. The company had recorded break-even earnings in the year-ago quarter.See the Zacks Earnings Calendar to stay ahead of market-making news.Total revenues in the fourth quarter were $90.5 million, which also missed the Zacks Consensus Estimate of$92 million. The top line decreased almost 23% year over year due to the decrease in collaborative arrange ...